Dr. John Leonard Discusses Use of Lenalidomide + Rituximab in Patients with Recurrent Follicular Lymphoma

In this video clip from OncLive Lymphoma Program Director, John Leonard, MD discusses the combination of lenalidomide and rituximab in patients with recurrent follicular lymphoma.

Unknown's avatar

Author: lymphomaprogram

Located on the Upper East Side of New York City, the Lymphoma Program at Weill Cornell Medical College/NewYork Presbyterian Hospital is internationally recognized for our efforts to enable patients with non-Hodgkin lymphoma, Hodgkin disease and related disorders to have the best possible clinical outcome, including cure when possible.

Post a Comment